June 20, 2026 04:22 pm (IST)
After Maggi and Knorr Top Ramen the latest casualty on safety ground
New Delhi, June 30 (IBNS) After Maggi controversy, central food safety regulator Food Safety and Standards Authority of India (FSSAI) has forced 'Top Ramen' noodles to be off-shelved in the Indian market.
"Since Top Ramen product approval is pending with the regulator. They have requested us to withdraw the product until they give the product approval," Indo Nissin Foods Pvt Ltd Managing Director Gautam Sharma said in a statement on Monday.
He further said Top Ramen was extensively tested in the last few weeks after product safety concerns arose in the category.
He further said Top Ramen was extensively tested in the last few weeks after product safety concerns arose in the category.
Instant nooles ran into a deep tourble as FSSAI already banned Nestle India's Maggi noodles while Hindustan Unilever also withdrew its Knorr instant noodles brand over safety and regulatory issues.
On June 8, FSSAI had come out with the advisory on product safety testing of all instant noodle products in India after lead beyond permissible limits in Maggi noodles along with taste enhancer Monosodium glutamate (MSG).
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
No big cuts, faster healing: Kolkata's BM Birla Heart Hospital launches robotic-assisted heart surgery
Tue, Jun 16 2026
Alembic Pharmaceuticals Limited announces USFDA final approval for Tretinoin Cream USP, 0.05%
Mon, Jun 15 2026
USD 1,000 in the US vs USD 25 in India: American woman’s viral video claims shocking drug price gap
Sat, Jun 13 2026
World's first AI-created universal COVID vaccine clears human trial milestone. Key details inside
Tue, Jun 09 2026
